Firms

Oxford Science Enterprises

oxfordscienceenterprises.com

Oxford Science Enterprises plc is an independent investment company and venture builder that creates, funds and develops companies emerging from University of Oxford research. Its focus spans deep tech, life sciences and health technology, including quantum computing, artificial intelligence, photonics, biomedical engineering and therapeutics. Its patient-capital model supports ventures from formation through growth. The operating platform began in 2015; its legal company09093331 was incorporated on19June2014 and was formerly Oxford Sciences Innovation plc until September2021. OSE Manager Limited is a separate wholly owned regulated subsidiary. The public directory includes executives, investment teams, central staff, entrepreneurs and scientists in residence, advisers and non-executive directors; those affiliations are distinguished by their published titles. Corporate equity raised, portfolio value, cumulative co-investment and net asset value are not represented as new LP fund closes. Complete portfolio transaction history and separate regulated-subsidiary identity remain under audit.

Founded

2015

Type

Venture capital

Team

Operations and support

Alex HammacherHead of Strategic Operations & Corporate Finance

Alicia MederickTeam Co-ordinator

Andre Crawford-BruntNon-Executive Director

Andrew StraitonSenior Associate, Deep Tech

Andy PenfoldContent Lead

Antonia JenkinsonChief Financial Officer

Athene BlakemanGeneral Counsel

Benny AxtEntrepreneur-in-Residence, HealthTech

Bernard TaylorNon-Executive Director

Brendan BolandEntrepreneur-in-Residence, HealthTech

Charo BajoData & Projects Manager

Chris ChambersNon-Executive Chairman

Christopher AshtonAdvisor, Life Sciences

Claire BrownPartner, Life Sciences

Clare GumbleyPortfolio Talent Lead, Life Sciences

Craig FoxOperating Partner, Life Sciences

Céline LeclereExecutive Assistant, HealthTech

Daoud KhanFinance Manager

Ed BusseyChief Executive Officer

Emily MatthewsResponsible Investment & ESG Manager

Fiona MurrayNon-Executive Director

Gaëlle NewtonEvents Manager

George ToddPrincipal, Deep Tech

Harry CliffordEntrepreneur-in-Residence, HealthTech

Heather RoxboroughSenior Partner, Head of HealthTech

Iwona Dombek-WieczorekFinance Officer

Jack EdmondsonChief Investment Officer

Jack StrudleyHead of Finance

James FinlaysonEntrepreneur-in-Residence, Deep Tech

Jeanette LovisExecutive Assistant

Jeff MooreSenior Partner, Head of Life Sciences

Joel SchoppigPartner, HealthTech

John RobertsSenior Compliance Manager

Jon HeppleAdvisor, Life Sciences

Jon WallPortfolio Talent Lead, Deep Tech

Katharina RamshornSenior Associate, Life Sciences

Katherine WardOperating Partner, HealthTech

Katya SmirnyaginaAdvisor, Life Sciences

Lauren LaingPrincipal, HealthTech

Liliane ChamasPrincipal, HealthTech

Lilly BussmannPartner

Lisa BedwellHead of Marketing

Mark ChadwickScientist-in-Residence, Deep Tech

Marlou HanselmannCommunications & Digital Marketing Executive

Martin FiennesAdvisor, Deep Tech

Matt MyersSenior Associate, Independent Investments

Matt NichollsAdvisor

Matthew HuntLegal Counsel

Molly StevensNon-Executive Director

Nick Dixon-CleggPartner, Head of Independent Investments

Nico BabaianEntrepreneur-in-Residence, HealthTech

Oliver MahonyPartner, Independent Investments

Paul GalluzzoEntrepreneur-in-Residence, HealthTech

Pete WilderHead of Property & Operations

Peter DonnellyNon-Executive Director

Peter Weston-SmithSenior Associate, HealthTech

Polly ElvinPartner, Capital Formation & Investor Relations

Rachel McKeeSenior People Advisor

Richard HobbsNon-Executive Director

Richard OakleyPrincipal, Deep Tech

Sally DewhurstPrincipal, Life Sciences

Sam HarmanPartner, Head of Deep Tech

Sam HarrisSenior Associate, Capital Formation & Investor Relations

Sami WalterSenior Associate, Deep Tech

Sanne De JonghPartner, Life Sciences

Satoko RobertsonExecutive Assistant & Legal Secretary

Sive OzerHead of Legal, Investing

Snigdha LalAssociate, Deep Tech

Suzanne AlgieTeam Co-Ordinator, Life Sciences

Tatiana Lobanov-RostovskyAssociate, HealthTech

Tony BessePrincipal, HealthTech

Wallace WallaceSenior Associate, Independent Investments

William GoodladAdvisor, Deep Tech

SHOW MORE

Co-investing

Cocoa

• Fractile$220M · 2026-05-15
• Fractile$15M · 2024-07-26

Kindred Capital

• Fractile$220M · 2026-05-15
• Fractile$15M · 2024-07-26

NATO Innovation Fund

• Fractile$220M · 2026-05-15
• Fractile$15M · 2024-07-26

Parkwalk Advisors

• Oxford Endovascular£8M · 2024-05-20
• Oxford Endovascular£7M · 2021-04-08

University of Oxford

• Oxford Endovascular£8M · 2024-05-20
• Oxford Endovascular£7M · 2021-04-08

SHOW MORE

Investments

$55M2025-07-31	Ultromics	Lightrock, Oxford Science Enterprises, GV, The Blue Venture Fund, UPMC Enterprises
$37M2026-09-15	ReEmerge	U.S. Venture Partners, Santé Ventures, Oxford Science Enterprises, IAG Capital Partners, The Vertical Group, Dendrion Ventures, 415 Capital
$220M2026-05-15	Fractile	Founders Fund, Accel, Factorial Funds, 8VC, Buckley Ventures, Gigascale Capital, Felicis, Conviction, 01 Advisors, Oxford Science Enterprises, Kindred Capital, NATO Innovation Fund, Cocoa
$12M2025-11-13	Scripta Therapeutics	Oxford Science Enterprises, Apollo Health Ventures, AlbionVC, YZR Capital
$15M2024-07-26	Fractile	Kindred Capital, NATO Innovation Fund, Oxford Science Enterprises, Inovia Capital, Hermann Hauser, Cocoa, Stan Boland, Amar Shah
£8M2024-05-20	Oxford Endovascular	Parkwalk Advisors, Norcliffe Capital, Vulpes, University of Oxford, Oxford Science Enterprises
$75M2022-01-20	ONI	ARCH Venture Partners, Casdin Capital, S32, Axon Partners Group, Vertical Venture Partners, Oxford Science Enterprises, Section 32
£7M2021-04-08	Oxford Endovascular	Vulpes, Parkwalk Advisors, Additio Investment Group, Perivoli Innovations, University of Oxford, OTIF Ventures, Oxford Science Enterprises
$—Unknown date	Acionna Therapeutics	Oxford Science Enterprises
$—Unknown date	EndLyz Therapeutics	Dementia Discovery Fund, Oxford Science Enterprises, AbbVie, KU Leuven, Parkinson's UK

SHOW MORE